InvestorsHub Logo
Followers 73
Posts 5766
Boards Moderated 0
Alias Born 12/02/2009

Re: hardlesson post# 65393

Monday, 04/01/2024 9:37:04 AM

Monday, April 01, 2024 9:37:04 AM

Post# of 65575
Eddie Chung, Coastar CEO: "This marks a thrilling juncture for both companies and the realm of gene editing," stated Eddie Chung, CEO of Coastar. "We're intrigued by the precision and integrase capabilities presented by the ABBIE system. This partnership will yield a novel platform applicable in both laboratory and clinical use."